Also known as Pancreas Cancer, Cancer Of The Pancreas, Pancreas Ca, and Malignant Neoplasm Of Pancreas
Pancreatic cancer is a malignant neoplasm originating from transformed cells arising in tissues forming the pancreas. The most common type of pancreatic cancer, accounting for 95% of these tumors, is adenocarcinoma (tumors exhibiting glandular architecture on light microscopy) arising within the exocrine component of the pancreas. A minority arise from islet cells, and are classified as neuroendocrine tumors. The signs and symptoms that eventually lead to the diagnosis depend on the location, the size, and the tissue type of the tumor, and may include abdominal pain, lower back pain, and jaundice (if the tumor compresses the bile duct).Source: Wikipedia
Within all the people who go to their doctor with pancreatic cancer, 49% report having sharp abdominal pain, 33% report having nausea, and 27% report having fatigue. The symptoms that are highly suggestive of pancreatic cancer are jaundice and stomach bloating, although you may still have pancreatic cancer without those symptoms.
Patients with pancreatic cancer often receive hematologic tests, complete blood count, glucose measurement, electrolytes panel, x-ray computed tomography, hemoglobin a1c measurement, therapeutic radiology for cancer treatment and cancer chemotherapy .
The most commonly prescribed drugs for patients with pancreatic cancer include gemcitabine (gemzar), dexamethasone, dexamethasone topical product, erlotinib (tarceva), palonosetron (aloxi), capecitabine (xeloda), prochlorperazine (compro), enoxaparin (lovenox), oxaliplatin, granisetron, pegfilgrastim (neulasta), fluorouracil and cetuximab (erbitux) .
|Dexamethasone Topical Product|
Groups of people at highest risk for pancreatic cancer include age 75+ years, age 60-74 years and age 45-59 years. On the other hand, age 5-14 years, age 1-4 years, age 15-29 years, and age < 1 years almost never get pancreatic cancer.